-
Mashup Score: 12
Please click the link to complete this form.
Source: form.jotform.comCategories: General Medicine News, Oncologists1Tweet
-
Mashup Score: 8Cased-Based Controversies in Locally Advanced NSCLC: A Radiation Oncology Update | IASLC - 9 day(s) ago
Dr. Stephen Chun (US) will moderate the program and lead the discussion following panel presentations by Dr. Andrea Filippi (Italy) and Dr. Pam Samson (US). As …
Source: www.iaslc.orgCategories: General Medicine News, Oncologists1Tweet-
The IASLC Advanced Radiation Technology Subcommittee of the Multidisciplinary Clinical Science Committee is hosting a webinar on radiation oncology for locally advanced #NSCLC, w/Dr. Stephen Chun, Dr. Andrea Filippi & Dr. Pam Samson. Register Now: https://t.co/jZm2qg8Lc7 #LCSM https://t.co/N1OAJ364P3
-
-
Mashup Score: 2
Join us at HTTR 2024 in Washington, DC, USA, for dynamic sessions that provide a comprehensive look at the molecular mechanisms that drive resistance to targ…
Source: www.youtube.comCategories: General Medicine News, Oncologists1Tweet-
Don’t miss #HTTR24! Join top cancer experts Dec 13-15 in Washington, D.C., at the IASLC Hot Topic Meeting. Co-chair Montse Sanchez-Cespedes https://t.co/CwYzsfGqk4 invites you to register for exclusive insights into the latest breakthroughs and trial results. Network,… https://t.co/bOE5WhjkSD https://t.co/P3XJ7bdq3m
-
-
Mashup Score: 2IASLC's Regional Course Series | IASLC - 10 day(s) ago
The International Association for the Study of Lung Cancer (IASLC) is the only global network dedicated to the study and eradication of lung cancer and other thoracic malignancies.
Source: www.iaslc.orgCategories: General Medicine News, Oncologists1Tweet-
Unlock the Power of Liquid Biopsy in Lung Cancer Care in LATAM! Join top LATAM experts for insights on cutting-edge applications across every stage of lung cancer. 📅 Choose Your Session: Nov 19 | 3:00 p.m. MDT Nov 21 | 4:00 p.m. MDT REGISTER NOW: https://t.co/pk2pJ9lclp https://t.co/TgE4YzU9VX
-
-
Mashup Score: 17IASLC | International Association for the Study of Lung Cancer - 10 day(s) ago
The International Association for the Study of Lung Cancer (IASLC) is the only global network dedicated to the study and eradication of lung cancer and other th …
Source: www.iaslc.orgCategories: General Medicine News, Onc News and JournalsTweet-
DID YOU KNOW? In May 1978, @IASLC's 1st WCLC in Hilton Head transformed #lungcancer history! 106 delegates from 16 countries paved the way for progress—new goals, elected officers, newsletters, & a significant membership surge! Explore more at https://t.co/v4T8q9uG4P #IASLC50 https://t.co/IdIwikFyhU
-
-
Mashup Score: 2
EGFR tyrosine kinase inhibitor (EGFR-TKI)-sensitizing and -resistance mutations may be detected in plasma through circulating tumor DNA (ctDNA). Circulating tumor DNA level changes reflect alterations in tumor burden and could be a dynamic indicator of treatment effect. This analysis aimed to determine whether longitudinal EGFR-mutation ctDNA testing could detect progressive disease (PD) before radiologic detection.
Source: www.jto.orgCategories: General Medicine News, Oncologists1Tweet-
In this analysis, aimed to determine whether longitudinal EGFR-mutation ctDNA testing could detect PD before radiologic detection, the authors concluded that longitudinal ctDNA monitoring may detect PD before radiologic PD. Read the details here: https://t.co/cZriVcrDdH #LCSM https://t.co/MCkoPsGZhr
-
-
Mashup Score: 41The Importance of Waiting for Biomarker Results in NSCLC | IASLC - 14 day(s) ago
Biomarkers are essential in lung cancer treatment, but they remain underutilized. In addition, clinicians and patients have to wait for those results before sta …
Source: www.iaslc.orgCategories: General Medicine News, Oncologists1Tweet-
Biomarkers are essential in #lungcancer treatment. Clinicians & pts have to wait for results before starting therapy. @StephenVLiu guides a discussion about biomarkers, & challenges/issues they create. W/guests @TurgemanIlit, Dr. Mark Kris, & Aurora Lucas: https://t.co/xLG8jXYqSt https://t.co/gHIH9xhpBI
-
-
Mashup Score: 13From Survivor to Advocate: Jim Pantelas Shares His Journey and Calls for Unity in the Fight Against Lung Cancer - 15 day(s) ago
Jim Pantelas, a 19-year lung cancer survivor and person who formally smoked, shares his journey and encourages others to join the advocacy for lung cancer. He says everyone’s voice is needed in this fight.
Source: voicesoftheiaslc.gv-one.comCategories: General Medicine News, Oncologists1Tweet-
Jim Pantelas, a #lungcancer survivor, shares his journey & emphasizes the importance of advocacy in the fight against lung cancer. Whether you're a survivor, caregiver, healthcare professional, or advocate, your story can make a difference! https://t.co/isFYYcP0LE #LCAM24 #LCSM https://t.co/Mx5uDfaONA
-
-
Mashup Score: 1Patient Perspective: Exercise Prescriptions Needed for Lung Cancer Patients - ILCN.org (ILCN/WCLC) - 17 day(s) ago
Runner and patient advocate Angus Pratt says running three times a week may be the antithesis of what most people expect from a lung cancer patient, but not only is it possible, it is beneficial.
Source: www.ilcn.orgCategories: General Medicine News, Oncologists1Tweet-
Runner & patient advocate Angus Pratt says running 3 times a week may be the antithesis of what most people expect from a #lungcancer patient, but not only is it possible, it is beneficial. Learn More: https://t.co/iuahflvZFm #LCAM24 #LCSM https://t.co/4Qij2sihyO
-
-
Mashup Score: 41IASLC Academy | IASLC - 18 day(s) ago
The IASLC Academy is a prestigious program geared toward early-career physicians worldwide who aspire to pursue academic careers in thoracic oncology.
Source: www.iaslc.orgCategories: General Medicine News, Oncologists1Tweet-
Are you ready to advance your career in thoracic oncology? The 2025 #IASLC Academy offers early-career physicians & researchers a transformative journey through mentorship, skill-building & hands-on learning. Don’t miss this chance! Learn More/Apply: https://t.co/L8ZAFVylLd #LCSM https://t.co/HZ1Jx0a2q1
-
🚨 Last Call for Abstracts! 🚨 The deadline for submitting your research to #TTLC2025 is TOMORROW at 23:59 MT! Don't miss this chance to present at the premier conference for IASLC 2025 Targeted Therapies of Lung Cancer. Submit now: https://t.co/ohJVtzZiis https://t.co/zVWp2IpYbu